Zobrazeno 1 - 4
of 4
pro vyhledávání: '"M C, Liance"'
Autor:
Raphaël David, Stachowiak J, B. Rio, G. A. Voisin, Norbert-Claude Gorin, J. Jansen, G. Le Blanc, P. Poncelet, Luc Douay, J. P. Laporte, M. Lopez, Albert Najman, Salmon C, Duhamel G, R. Zittoun, M. C. Liance, Deloux J, P. Cazellas
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::c1c7828255fc2345ba9b495f5b3636a9
https://doi.org/10.1159/000411719
https://doi.org/10.1159/000411719
Autor:
D. Carriere, D. Dussossoy, Pierre Casellas, F. K. Jansen, J. C. Laurent, P. Poncelet, B. Bourrie, M. C. Liance, G. Richer, H.E. Blythman, H. Vidal, O. Gros
Publikováno v:
Receptor-Mediated Targeting of Drugs ISBN: 9781468448641
Since 1980, immuno-A-toxins (I-A-Ts) which are conjugates between an antibody and the A-chain of a polypeptide toxin, e.g., diphtheria toxin or ricin, have been described by several laboratories as cytotoxic agents with high specificity for their tar
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::a5f2b95388f43a67a95736cab457ef1e
https://doi.org/10.1007/978-1-4684-4862-7_9
https://doi.org/10.1007/978-1-4684-4862-7_9
Autor:
P, Poncelet, H E, Blythman, D, Carriere, P, Casellas, D, Dussossoy, O, Gros, P, Gros, F K, Jansen, J C, Laurent, M C, Liance
Publikováno v:
Behring Institute Mitteilungen. (74)
Immuno-a-toxins (I-a-T) are hybrid molecules designed for a more selective therapy of cancer, which combine an antibody preferentially directed against tumour cells and the A-chain of the toxin ricin. Although a majority of them are highly and select
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::c9ffe01a221708e10ee0eefd69bb8cb9
https://pubmed.ncbi.nlm.nih.gov/6383330
https://pubmed.ncbi.nlm.nih.gov/6383330
Autor:
L, Douay, N C, Gorin, M, Lopez, P, Casellas, M C, Liance, F K, Jansen, G A, Voisin, C, Baillou, J P, Laporte, A, Najman
Publikováno v:
Cancer research. 45(1)
T101-ricin A-chain immunotoxin is a hybrid molecule made up of the T101 monoclonal antibody bound to the A-chain of ricin. It specifically destroys cells expressing the cell surface T65 antigen. We have designed a preclinical study to evaluate its po
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::e93534526a9fe5dfa19824bc4707bc0b
https://pubmed.ncbi.nlm.nih.gov/3880666
https://pubmed.ncbi.nlm.nih.gov/3880666